0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Commentary | 
Katherine E. Gundling, MD
Arch Intern Med. 1998;158(20):2185-2186. doi:10.1001/archinte.158.20.2185.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Editorial  | 
An Emerging Era of Clinical Benefit From Gene Therapy
Harry L. Malech, MD; Hans D. Ochs, MD
JAMA
Preliminary Communication  | 
Outcomes Following Gene Therapy in Patients With Severe Wiskott-Aldrich Syndrome
Salima Hacein-Bey Abina, PharmD, PhD; H. Bobby Gaspar, MRCP, PhD; Johanna Blondeau, MS; et al.
JAMA Ophthalmology
Original Investigation  | 
Prevention of Nocturnal Elevation of Intraocular Pressure by Gene Transfer of Dominant-Negative RhoA in Rats
Teresa Borrás, PhD; LaKisha K. Buie, BS; Maria-Grazia Spiga, PhD; et al.
JAMA Ophthalmology
Viewpoint  | 
The First International Optogenetic Therapies for Vision Symposium Translational Medicine in Progress
Marco A. Zarbin, MD, PhD